GT200800235A - Formulacion de medicamento liquida - Google Patents

Formulacion de medicamento liquida

Info

Publication number
GT200800235A
GT200800235A GT200800235A GT200800235A GT200800235A GT 200800235 A GT200800235 A GT 200800235A GT 200800235 A GT200800235 A GT 200800235A GT 200800235 A GT200800235 A GT 200800235A GT 200800235 A GT200800235 A GT 200800235A
Authority
GT
Guatemala
Prior art keywords
formulation
medicinal product
liquid medicinal
liquid
betablockers
Prior art date
Application number
GT200800235A
Other languages
English (en)
Inventor
Kanikanti Venkata-Rangarao
Beddies Gerald
Schulte Georg
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of GT200800235A publication Critical patent/GT200800235A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/08—Solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Emergency Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

LA INVENCIÓN SE REFIERE A UNA FORMULACIÓN DE MEDICAMENTO LÍQUIDA PARA BETABLOQUEANTES QUE ES ESPECIALMENTE ADECUADA PARA LA ADMINISTRACIÓN POR VÍA ORAL EN ANIMALES EN EL TRATAMIENTO DE ENFERMEDADES CARDIOVASCULARES. T2008
GT200800235A 2006-05-02 2008-10-29 Formulacion de medicamento liquida GT200800235A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102006020604A DE102006020604A1 (de) 2006-05-02 2006-05-02 Flüssige Arzneimittelformulierung

Publications (1)

Publication Number Publication Date
GT200800235A true GT200800235A (es) 2010-04-28

Family

ID=38180418

Family Applications (1)

Application Number Title Priority Date Filing Date
GT200800235A GT200800235A (es) 2006-05-02 2008-10-29 Formulacion de medicamento liquida

Country Status (23)

Country Link
US (1) US20090264535A1 (es)
EP (1) EP2015728A2 (es)
JP (1) JP2009535368A (es)
KR (1) KR20090014183A (es)
CN (1) CN101431981A (es)
AR (1) AR060730A1 (es)
AU (1) AU2007245911A1 (es)
BR (1) BRPI0711140A2 (es)
CA (1) CA2650786A1 (es)
CO (1) CO6180495A2 (es)
CR (1) CR10407A (es)
DE (1) DE102006020604A1 (es)
EC (1) ECSP088850A (es)
GT (1) GT200800235A (es)
IL (1) IL195034A0 (es)
MX (1) MX2008013873A (es)
PE (1) PE20080149A1 (es)
RU (1) RU2008147216A (es)
SV (1) SV2008003080A (es)
TW (1) TW200808373A (es)
UY (1) UY30315A1 (es)
WO (1) WO2007124869A2 (es)
ZA (1) ZA200809269B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2011507918A (ja) * 2007-12-27 2011-03-10 バイエル・アニマル・ヘルス・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング β−遮断薬を使用する心疾患の処置
EP2246044A1 (en) * 2009-04-21 2010-11-03 Pierre Fabre Dermo-Cosmétique Paediatric solutions comprising a beta-blocker
KR20150120008A (ko) * 2014-04-16 2015-10-27 씨제이헬스케어 주식회사 비소프롤롤 및 로수바스타틴을 포함하는 경구용 약제학적 복합제제
EA033298B1 (ru) 2015-03-03 2019-09-30 Саниона А/С Комбинированная лекарственная форма тезофензина и метопролола
GB202207690D0 (en) * 2022-05-25 2022-07-06 Zentiva Ks Liquid pharmaceutical formulation of bisoprolol

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6051106A (ja) * 1983-08-31 1985-03-22 Yamanouchi Pharmaceut Co Ltd 塩酸アモスラロ−ル持続性製剤
US4600708A (en) * 1985-07-19 1986-07-15 American Home Products Corporation Propranolol hydrochloride liquid formulations
GB9102579D0 (en) * 1991-01-24 1991-03-27 Glaxo Group Ltd Compositions
HU209251B (en) * 1992-03-13 1994-04-28 Synepos Ag Process for producing stable, peroral solution drug forms with controlled release of active ingredient and comprising beta-blocking pharmacons
WO1999016417A1 (en) * 1997-10-01 1999-04-08 Flemington Pharmaceutical Corporation Buccal, polar and non-polar spray or capsule
US6159458A (en) * 1997-11-04 2000-12-12 Insite Vision Sustained release ophthalmic compositions containing water soluble medicaments
US6335335B2 (en) * 1997-11-05 2002-01-01 Senju Pharmaceutical Co., Ltd. Prolonged-action eye drop
US6664284B2 (en) * 1998-07-23 2003-12-16 Roche Diagnostics Gmbh Stabilized carvedilol injection solution
WO2003028718A1 (en) * 2001-10-01 2003-04-10 Smithkline Beecham Corporation Novel formulations of carvedilol

Also Published As

Publication number Publication date
RU2008147216A (ru) 2010-06-10
BRPI0711140A2 (pt) 2011-08-23
CO6180495A2 (es) 2010-07-19
CN101431981A (zh) 2009-05-13
EP2015728A2 (de) 2009-01-21
AU2007245911A1 (en) 2007-11-08
WO2007124869A3 (de) 2008-04-17
TW200808373A (en) 2008-02-16
KR20090014183A (ko) 2009-02-06
MX2008013873A (es) 2008-11-14
UY30315A1 (es) 2007-11-30
CR10407A (es) 2009-03-30
CA2650786A1 (en) 2007-11-08
SV2008003080A (es) 2009-11-26
JP2009535368A (ja) 2009-10-01
AR060730A1 (es) 2008-07-10
ZA200809269B (en) 2009-12-30
IL195034A0 (en) 2009-08-03
PE20080149A1 (es) 2008-04-06
ECSP088850A (es) 2008-12-30
WO2007124869A2 (de) 2007-11-08
US20090264535A1 (en) 2009-10-22
DE102006020604A1 (de) 2007-11-08

Similar Documents

Publication Publication Date Title
CL2008003582A1 (es) Uso de una composicion farmaceutica que contiene cisteamina o cistamina en la preparacion de un medicamento util para el tratamiento de una enfermedad de higado graso no alcholico (nafld) o esteatohepatitis no alcoholica (nash).
EA200802208A1 (ru) Применение флибансерина для лечения расстройств полового влечения в постклимактерический период
GT200600260A (es) Derivados de benzamida y usos relacionados con los mismos
GT201100127A (es) Moduladores de aril metil benzoquinazolinona alostéricos positivos del receptor m1
DOP2007000053A (es) Compuestos de tetrahidropiridotienopirimidina y métodos para su empleo
GT201400069A (es) Composiciones farmaceuticas
HN2008001666A (es) Derivados acidos de cicloalquilamino
GT201400059A (es) Derivados de estra-1,3,5(10),16-tetraen-3-carboxamida, proceidmientos para su preparación, preparados farmacéuticos que los contienen, así como su uso para la preparacion de medicamentos
CO6491060A2 (es) Compuestos y composiciones para el tratamiento de enfermedades parasitarias
UA101903C2 (ru) Лекарственное средство на основе дииндолилметана для лечения гиперпластических и воспалительных заболеваний
CY1115725T1 (el) Ενωσεις, συνθεσεις και μεθοδοι για την θεραπευτικη αγωγη των βητα-αμυλοειδικων ασθενειων και συνουκλεϊνοπαθειων
BR102013003570A8 (pt) Composições de plasma rico em plaquetas
CL2011002766A1 (es) Compuestos derivados de carboxamida, inhibidores de calpaina; composicion farmaceutica que los comprende; y su uso en el tratamiento de enfermedades neurodegenerativas, alzahimer, dolor, entre otras.
CL2013003630A1 (es) Formulacion farmaceutica liquida que comprende nitisinona y un tampon de acido citrico que tien un ph en el rango de 2,5 a 3,5, de preferencia 3,0; y su uso para el tratamiento de tirosemia, enfermedad de parkinson, depresion, entre otros.
BR112015029897A2 (pt) composição sólida para administração oral contendo ácido ibandrônico ou um seu sal farmaceuticamente aceitável e vitamina d e processo para obtenção da referida composição
NO20084478L (no) Konjugerte lipidderivater
UY31322A1 (es) Amidas heterocíclicas y sus métodos de uso-975
GT200800235A (es) Formulacion de medicamento liquida
ATE452120T1 (de) Fettsäure-benzenediol-derivate sowie herstellungs-und verwendungsverfahren dafür
MA32635B1 (fr) Produit medicamenteux et traitement associe
CR11734A (es) Uso de dronedarona o una sal aceptable farmaceuticamente de esta, para la preparacion de un medicamento para regular el nivel de potasio en la sangre
CL2010001577A1 (es) Uso de nifurtimox para preparar un medicamento util en el tratamiento de enfermedades causadas por giardias.
PE20090625A1 (es) Composicion farmaceutica que contiene buprenorfina y nalmefeno
BR112015001627A2 (pt) composição farmacêutica, respectivos usos e método para diminuir a frequência de micção
GT200500032A (es) Piperazinas derivadas de urea para el tratamiento de la endometrosis